TITHON BIOTECH - Key Persons
Biography
Dr Reich is best known for pioneering Total Laparoscopic Hysterectomy (TLH) and the development of radical excisional laparoscopic techniques for the removal of extensive and deep endometriosis - pivotal moments in the development of gynecological surgery. These techniques are now recognized as a "gold standard method" and are imitated in most specialist endometriosis centers worldwide, making Dr Reich one of the most influential gynecological surgeons of the late 20th century.
Biography
Dr. Joseph Purita, a pioneer in the use of the laser in orthopedic surgery, graduated from Georgetown University Medical School and served his surgical internship at the University of Florida Medical Center. Following completion of a residency in orthopedic surgery at University of Miami-Jackson Memorial Hospital, where he served as chief administrative resident, Dr. Purita joined the Boca Raton Orthopedic Group in 1981. Dr. Purita is a Fellow of the American Academy of Orthopedic Surgeons, the American College of Surgeons and the American Medical Association. Dr. Purita is on the Amrecian Board of Orthopedic Surgery, American College of Orthopaedic Surgery and the American Board of Pain Management. Dr. Purita is an instructor and proctor of surgeons in the use of lasers in arthroscopic and orthopedic surgery at a variety of area hospitals. The Physicians at Doximity named Dr. Joseph Purita one of US News and World Report's "Top Doctors"! He is one of the world's leading instructors in the use of autologous therapies such as platelet rich plasma and bone marrow. He is on the Faculty of the Stem Cell Fellowship of the American Academy of Anti-Aging Medicine will present didactic Lectures and perform practical lectures
He has also done missionary work at Caridad Center Free Medical Clinic at Boynton Beach FL, volunteer as an Orthopedic surgeon for project Medishare in Haiti and as Chief Orthopedic Surgeon at Airport Field Hospital Port Au Prince, Haiti. Dr. Purita is an Instructor and proctor of surgeons in the use of lasers in arthroscopic and orthopedic surgery at a variety of area hospitals.
Biography
During his 32 year career in obstetrics and gynaecology, Dr Nick Lolatgis has played a leading role in many of the pioneering developments in women's health care; and today, is acknowledged as a world authority on devising and implementing advanced strategies for improving the success of treating all male and female infertility problems.
Under his leadership and care, the recently formed Centre for Infertility Solutions (CIS) is now providing all couples with a highly personalised and pro-active approach to overcoming difficulties with conceiving and successfully completing a pregnancy through combining both Immunological and IVF avenues of treatment.
Dr Nick Lolatgis is an Honorary Lecturer in the department of Obstetrics and Gynaecology at Monash University; a Director of the Monash Family Planning Service; and was a previous Director of the Epworth Endometriosis Centre in Melbourne.
Dr. Charles Mahl joins Tithon's Scientific and Medical Advisory Board
Biography
Dr. Mahl is a graduate of the Rosalind Franklin School of Medicine (Chicago Medical School) in Chicago, Illinois (M.D.) and Case Western Reserve University in Cleveland, Ohio (B.A.). He is a Fellow of the American College of Surgeons (FACS) and also a Fellow of the International College of Surgeons (FICS), and is a Diplomate of the National Board of Medical Examiners. He is a Fellow of the American Society for Laser Medicine and Surgery (FASLMS). He is also Board Certified in Ophthalmology by the American Board of Ophthalmology (Diplomate Status) and Fellowship trained in Vitreoretinal Diseases and Surgery. He is a Fellow and Charter Member of the American Board of Eye Surgery (FACES). In his second career path, Charles started learning and practicing ant-aging, Orthopaedic and regenerative medicine. He has been an active member of the Interventional Orthopedic Foundation, participating in the Wounded Warriors Program for soldiers and veterans. As a member of the American Association of Orthopedic Medicine (AAOM), he has participated in their medical missions with the American Osteopathic Association of Prolotherapy and Regenerative Medicine (AOAPRM), he has lectured and proctored other physicians in Regenerative Medicine. Dr. Mahl is certified in Age Management Medicine and has completed Fellowships by the American Academy of Anti-Aging Medicine, the Age Management Medical Group and the Living Younger System of Preventive Aging. He is certified in Integrative Medicine (Diplomate Status) in Sports Nutrition (CSN) and certified in Personal Training (CPT). He is a member of the Florida Medical Reserve Core and Miami-Dade Medical Reserve Core/Department of Homeland Security (FEMA) to assist in any type of local or national disaster for emergency as a Physician Volunteer. Dr. Mahl is a member of numerous other professional organizations within the fields of pain management, regenerative medicine, and anti-aging medicine, and helps in assessing and developing new products and techniques. He Co-Chairs the American Association of Orthopedic Medicine Annual Meeting and is President-Elect for 2021-2023.
Dr. Terry Grossman joins Tithon's Scientific and Medical Advisory Board
Biography
Terry Grossman, MD is one of America's leading authorities in the field of anti-aging, longevity medicine and life extension therapies. He has co-authored two books with famed inventor and futurist Ray Kurzweil, Transcend, Nine Steps to Living Well Forever (2010) and the best seller Fantastic Voyage: Live Long Enough to Live Forever (2004). Dr. Grossman has written numerous articles for health-related magazines and lectures frequently on topics related to anti-aging medicine throughout the United States and internationally to both lay and professional audiences.
Dr. Grossman received his M.D. from the University of Florida School of Medicine in 1979. Following his postgraduate training at St. Joseph Hospital in Denver, he spent 15 years (from 1980-1994) as a community family doctor before opening Grossman Wellness Center in Denver, Colorado in 1995. His clinic emphasizes advanced nutritional therapies and preventive, anti-aging medicine. Grossman has developed numerous cutting-edge protocols for measuring and modifying biological age and promoting longevity. Patients from all areas of the United States and every continent worldwide come to Grossman Wellness Center to experience comprehensive health evaluations. He is also the international medical director for Vitallife, the wellness division of Bumrungrad Hospital in Bangkok, Thailand.
Dr. Grossman has been involved in regenerative medicine since 2009 and is the co-founder of the American Academy and Board of Regenerative Medicine (AABRM).
Job Titles:
- Chief Medical and Scientific Officer
- Professor of Pharmacology
George Kolios is Professor of Pharmacology in the School of Medicine at the Democritus University of Thrace, Alexandroupolis, Greece. He obtained his first degree in Medicine in 1980. In 1992, he obtained his PhD degree in Gastroenterology from the School of Medicine at the University of Athens, Greece and in 1998, his PhD degree in Pharmacology from the Department of Pharmacology at the University of Bath, United Kingdom. In 1990, he finished his Specialization in Gastroenterology and he first worked as Registrar in Gastroenterology at the Royal United Hospital, Bath, United Kingdom and then as Senior Registrar in the Gastroenterology Department at the Hippokration General Hospital, Athens, Greece. From 1998 till 2001, he worked as Consultant Gastroenterologist at the Royal United Hospital, Bath, and Senior Research Fellow in the Department of Pharmacology at the University of Bath, United Kingdom. In 2001, he was appointed Assistant Professor of Gastroenterology in the School of Medicine at the University of Crete and Visiting Professor in Pharmacology at the University of Bath, United Kingdom. From 2008 till today, he is a Professor of Pharmacology in the School of Medicine at the Democritus University of Thrace, Alexandroupolis, Greece and Director of the Master's Degree Program "Clinical Pharmacology and Therapeutics" that is organized by the School of Medicine of Democritus University of Thrace. From 2008 till 2013, he was Member of the Scientific Board of Approvals of the Greek National Organization for Medicines. From 2013 till today, Professor Kolios is Vise-President of the School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Professor George Kolios is an experienced Clinical Gastroenterologist, and a very productive research scientist, with an extensive work in the area of immunopharmacology, mucosal immunology and fibrosis, mainly focused on the intestinal inflammation and Inflammatory Bowel Diseases. His work has demonstrated that the mucosal epithelium could be a rich source of various inflammatory mediators, including cytokines, chemokines and nitric oxide, which are involved in inflammation and fibrosis, and that these pro-inflammatory systems can be modified by cytokines derived by T-cell population. In addition, his work has been focused on the biology and the role of gut subepithelial myofibroblasts in fibrosis and on the interplay between gut mucosal immunity and microbiota. He has more than 80 papers in peer reviewed journals, which have been cited more than 3100 times with an h-index: 31.
Mr. David R. Strawn, over the past 38 years, has engaged in the practice of securities law, as an attorney, and has participated, as a private investor, in various business ventures. As a practicing attorney, Mr. Strawn has represented: registered broker dealers, venture capital investors, public reporting companies, issuers in private and IPO transactions, private and public companies in acquisition transactions, domestic broker-dealers and foreign broker-dealers engaged in cross boarder business and has participated in the development of an online Internet based trading system providing both order execution in trading securities and an online investment banking platform. Mr. Strawn has worked extensively in offshore financial markets and participated in the development of cross border PATRIOT Act compliance programs. As a private investor, Mr. Strawn has participated in the strategic planning, development and funding of start-up companies, and acquisition and collaboration transactions involving early stage growth and mid-cap companies engaged in various industries, including: mining and natural resources, healthcare, biosciences, financial services, telecommunication, construction and transportation. Mr. Strawn graduated from Portland State University, summa cum laude, with a degree in finance in 1977 and from the University of Arizona-Arizona School of Law, with honors, with a Juris Doctorate degree in 1980. Mr. Strawn resides in San Diego, California.
Job Titles:
- Director and CEO of AMALNA Consulting
Mr. Drasko Cosic is Director and CEO of AMALNA Consulting, engaged in consulting regarding the Resonant Recognition Model which has been developed by Professor Irena Cosic. As director and CEO, Drasko is responsible for all software and business matters of the company.
Mr. Cosic graduated electrical and computer engineering. For over 35 years he has been involved in IT software development working with companies like UNISYS, JAT, Energoproject and ComOps. He has also been involved in the development of Resonant Recognition Model software since the beginning of its development in mid 1980s and is the author of different versions of the Resonant Recognition Model software.
Job Titles:
- Chief Executive Officer
- Member of the MANAGEMENT Team
Greg has over 40 years experience in the healthcare provider system working for providers of Care and Information Technology and Services companies in roles such as consulting, marketing, investor relations and new business development, working in both the Public and Private Health Sector, and performing a number of roles as both the vendor, client representative and industry consultant.
His roles include leading marketing, communications and investor relation's functions in numerous early start health technology companies through to working for a health technology company for over 5 years which was dual-listed on the UK and Australian stock exchange with a market capitalization of over 1/2 billion dollars.
Greg has worked in Australia, New Zealand, South Africa, UK and the US and more recently SE Asia (and China) ranging from large multi-entity health delivery systems in Asia and China through to Private Hospitals in Australia, multi-entity hospital organisation in New Zealand, NSW Area Health Services, and a multi-entity payer based management solutions in the USA.
Across Asia and Greater China Greg has been involved in multiple company acquisitions, integration and subsequent board level and management of the acquired Asian companies.
Working together and alongside some of China's largest telecommunications, internet, health media and healthcare organizations, Greg led a team from international software provider iSOFT developing and deploying health care services based on a converged service of video+social media over the internet and mobile devices.
Mr. Greg King joins Tithon Biotech as its Chief Executive Officer
Peter was educated in Melbourne, Australia, firstly at La Trobe University, where he completed a Bachelor Degree (Social Sciences) after undertaking studies across a diverse range of disciplines, including Science, Law and Arts, and later at Monash University, where he completed Pharmaceutical Industry specific Post Graduate (APMA CEP) qualifications. His career followed his passion, Health Care, and for the last 20 years he has worked in the Pharmaceutical Industry, developing extensive knowledge and experience in Sales, Marketing and Management across a number of therapeutic areas and medical sectors such as: Biotechnology, Cosmetic Medicine, Ophthalmology, Women's Health, Surgical & Capital Equipment, Gastroenterology, CNS, Hospital, Aged Care and Pharmacy. From his early beginnings as a Sales Representative, on the front line, to Business Development, and National Sales & Marketing Management, all the way through to, Chief Operating Officer, and Director, Peter has a complete understanding, and perspective, of the intricate world of the Health Care and Pharmaceutical business. His expertise in this area has been acquired over 2 decades of working for some major Health Care/Pharmaceutical organisations in the industry including: WYETH AYERST and LEDERLE LABORATORIES, international pharmaceutical company, specialising in areas such as, Women's health, Gastroenterology, Vaccine and CNS markets; ALCON LABORATORIES & SURGICAL, an international company specialising in the discovery, development, manufacture and marketing of surgical devices, vision care products and ophthalmic pharmaceuticals; and AUSTRALASIAN MEDICAL & SCIENTIFIC established with the aim of providing the Australian scientific and medical markets with a range of leading edge products from around the world. In the last two years Peter has been instrumental in the development of the business around the incorporated technologies into Adilyfe as he was working as the Business Development Manager of Adistem, General Manager of Paspa Pharmaceuticals, Director and Vice president of Black Arrow Biotech and Chief Operating Officer of Nereen Healthcare.
Biography
Prof Demosthenes Bouros is a graduate of the Medical School of the Aristotelian University of Thessaloniki (1975) and a PhD of the University of Athens (1988). He was a research fellow at the Harvard University in Boston and Visiting Assistant Professor at the Boston University (1986-1988). He spent his sabbatical as a Senior Research Associate at the Royal Brompton Hospital, and the National Heart and Lung Institute-Interstitial Lung Disease Unit at the Imperial College of London, UK (1998-1999). He elected assistant Professor in Pneumonology at the Medical School, University of Crete (1989), associate Professor (1995-2002) and Professor of Pneumonology at the University of Thrace, Greece (2002-). European Respiratory Society Visiting professor at the Medical University of Vienna (2010). He served as vice chair/chair of the Department of Pneumonology at the University of Crete and the University Hospital of Heraklion, Greece. He also served as director of the Emergency Department, and chairman of the Department of internal medicine at the University Hospital of Heraklion, Crete and member of the University of Crete Senate. Currently, he is Professor of Pneumonology at the University of Thrace and head of the Department of Pneumonology at the University Hospital of Alexandroupolis. He is also serves as chairman of the Dept of Internal Medicine of the University Hospital of Alexandroupolis and chairman of the Dept of Internal Medicine of the Democritus University of Thrace. He is member of the board of the Medical School of the Democritus University of Thrace, the University Hospital of Alexandroupolis, and the National Council of Health (KESY). He is author of a book entitled ‘Basic principles of clinical pharmacology and therapeutics' (1999 and 2005 2nd ed.), editor of a book entitled "Pleural Diseases" (Marcel Dekker NY, 2004, and 2nd ed, Informa NY, 2009) of the series Lung Biology on Health and Disease published by the NIH (USA). He has published >400 articles in national and international peer-review journals, has >4300 citations, H index 36, he wrote >40 chapters in books in Greek and English, is member of the 2 Editorial Board of many medical journals (EIC: Pneumon, Associate Editor: RESPIRATION, BMC-Pulmonary Medicine, BMC-research notes; EB member: CHEST, Eur Respir Topic, Future Drugs, Newsletter on Pleural Disease, etc), reviewer in many journals (including Lancet, BMJ, AJRCCM, ERJ, Chest, Thorax, PMJ, EJCI, Respir Med, BMC series, Tubercle, ICM), and member of many international medical societies (ERS, ATS, ACCP, WASOG, ACC Pharmacology, etc). He has been section editor for pleural diseases update (Respiration, 2008) and interstitial lung diseases (Current Opinion in Pulmonary Medicine, 2011). He participated in the development of the European Respiratory Society (ERS) official statements for COPD (1995), Tuberculosis management in Europe (1999) and Interstitial Lung Disease (2001). He was a member of the committee for the development of the new ATS/ERS/JRS guidelines for idiopathic pulmonary fibrosis (2007-2010) and the new classification of idiopathic interstitial pneumonias (2010-2012). Is reviewer for the published ERS consensus statement for lymphangioleiomyomatosis (LAM, 2010). He collaborates with many scientists in Europe and the US. He has been elected and served as National Delegate at of the ERS (1999-2003), was a member of the council and the nomination committee of the ERS (2002-2003), and a member of the long-range planning committee of the American Thoracic Society (ATS) and the ERS. He served as auditor of the ERS (2004-2007) and is a member of the Assembly on Allergy, Inflammation and Immunology (AII) Program Committee of the ATS. His main research interests include the pathophysiologic/pathogenetic mechanisms and treatment of interstitial lung diseases and the pleural diseases.
Biography
Professor Fändrich is the Director of the Dept. of Applied Cellular Medicine, at the University Hospital of Schleswig-Holstein, Kiel, Germany and the founder of Blasticon, the owner of a patented technology which monocytes (mature white blood cells) from blood extracted from the veins can be turned into cells with programmable properties such as those in stem cell and in turn be used for diverse applications in diagnostics and treatments.
He is the President of the European Society for Autoimmune Disease (EGAI) and is also one of five opinion leaders, World Transplant Society, Oxford, UK. Up to 2009, Professor Fändrich was a Professor of Surgery specializing in transplantation medicines. He later decided to direct his focus into the field of cellular medicine at the University of Kiel.
Professor Fändrich has been the recipient of many awards including Outstanding Physics Award, University of CA, Riverside, the Rudolf-Pichlmayr-Award for outstanding research in the field of peptide and stem-cell mediated tolerance induction, German Society of Surgery (DGC) and the GEORG-HEBERER-Award, Chiles Foundation Portland, Oregon.
He has published many scientific papers and clinical reviews under references for Transplantation, Oncology, Regenerative and Cellular Medicine, Immunotherapy and made contributions to clinical reference books.
Job Titles:
- Chairman
- Member of the MANAGEMENT Team
- President
Vasilis has worked at and consulted for a number of pharmaceutical and biotech companies globally. Due to his innovation he has been the founder and director of seven biotech companies since 2000. In early 2006, he founded Adistem, Ltd in Hong Kong. After finishing his doctorate in pharmacology/endocrinology in 1993 at St Vincent's Institute of Medical Research at the University of Melbourne, he completed his post-doctoral fellowship at Pfizer Central Research in Connecticut. During this time he was given two scholarships from the Australian Federal Government, and the National Health and Medical research Council of Australia and two young investigators awards in osteoporosis research from the Australian and New Zealand Bone and Mineral Society, and the International Society for Bone and Mineral Research. After doing his clinical training in Greece, he worked in combat trauma medicine in Africa where he stayed and did humanitarian work in Angola. In 2008, Dr. Paspaliaris received an Appreciation Award from the American Association of Clinical Endocrinologists for his groundbreaking work on adipose-derived stem cells in Type II diabetes and two certificates of appreciation from the American Academy of Anti-Aging Medicine on his stem cell research and an investigators award from the Hellenic Thoracic Society. Dr. Paspaliaris has published over 20 papers, holds over 5 patents and given lectures in a variety of medical fields, mostly in stem cell medicine. He is currently a Faculty Member for the Masters degree program in Clinical Pharmacology and Therapeutics at Democritus University Medical School and the University of Crete in Greece. He is a member of the World Society of Interdisciplinary Anti-aging Medicine, the Australian Military Medicine Association and Latin American Stem Cell Society, a Fellow of the Philippine Society of Stem Cell Medicine, a Diplomat of the American Board of Regenerative Medicine, a Fellow of the American Academy of Regenerative Medicine and a Fellow of the Royal Society of Medicine (UK).